Clin Infect Dis. 2003 Feb 1;36(3):e35-9. Epub 2003 Jan 17. Related Articles, Links

Comment in:
Clin Infect Dis. 2003 Sep 1;37(5):738.

Bradycardic syncope in 2 patients who recently began gatifloxacin treatment.

Nicholson WJ, Buxton AE, Tammaro D.

Department of Medicine, Rhode Island Hospital, Brown Medical School, Providence, Rhode Island 02903, USA.

Gatifloxacin is a synthetic broad-spectrum 8-methoxyfluoroquinolone approved by the United States Food and Drug Administration in December 1999. Few side effects of this new antibiotic have been reported, and there are no previous case reports of bradyarrhythmias. We report 2 cases of syncope due to bradycardia in patients who recently began treatment with gatifloxacin.

Publication Types:
Case Reports

PMID: 12539087 [PubMed - indexed for MEDLINE